Table 2

Amino acid heterogeneity of V3 region of HIV-1 proviral quasispecies harboured by monocytes (CD36) and T lymphocytes (CD26) and of plasma virions replicating in the two cell types after HAART interruption.

Patient

Sample type

N. of unique variants*

Diversity**

Complexity***


Pt.1

Provirus

CD36

161

0.0795 ± 0.0005

0.3798


CD26

226

0.0197 ± 0.0001

0.2119


Pt.2

Provirus

CD36

231

0.1446 ± 0.0005

0.3620


CD26

59

0.0031 ± 0.0001

0.0919


Pt.3

Provirus

CD36

46

0.0508 ± 0.0003

0.3042


CD26

3

0.0084 ± 0.0002

0.0738


Virus

CD36

26

0.0428 ± 0.0010

0.2979

CD26

158

0.0298 ± 0.0003

0.3293


Pt.4

Provirus

CD36

76

0.0226 ± 0.0007

0.1127


CD26

14

0.0457 ± 0.0003

0.1755


Virus

CD36

15

0.0113 ± 0.0002

0.1138


CD26

41

0.0208 ± 0.0002

0.1222


Pt.5

Provirus

CD36

157

0.0585 ± 0.0003

0.2756


CD26

120

0.0411 ± 0.0004

0.4233


Virus

CD36

305

0.0728 ± 0.0005

0.3664


CD26

38

0.0042 ± 0.0001

0.0870


Sequences obtained by ultra-deep pyrosequencing were filtered through the correction algorithm and amino acid sequences obtained were analyzed to establish diversity and complexity, as described in the Materials and Methods section.

* Number of unique sequences obtained after dereplication

** Diversity: p distance ± SEM

*** Complexity: normalized Shannon entropy

Rozera et al. Retrovirology 2009 6:15   doi:10.1186/1742-4690-6-15

Open Data